HKU Scholars Hub: Browsing DSpace

Browsing by Author Uronis, HE

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 7 of 7

	Title	Author(s)	Issue Date	Views
	A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer Journal:The Oncologist	Vlahovic, G Meadows, KL Hatch, AJ Jia, J Nixon, A Uronis, HE Morse, MA Selim, MA Crawford, J Riedel, R Zafar, SY Howard, LA O'Neill, M Meadows, JJ Haley, ST Arrowood, CC Rushing, C Pang, H Hurwitz, HI	2018	31
	A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas Journal:Oncologist	Uronis, HE Bendell, JC Altomare, I Blobe, GC David Hsu, S Morse, MA Pang, H Yousuf Zafar, S Conkling, P Favaro, J Arrowood, CC Cushman, SM Meadows, KL Brady, JC Nixon, AB Hurwitz, HI	2013	64
	A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer Journal:Oncologist	Altomare, I Bendell, JC Bullock, KE Uronis, HE Morse, MA Hsu, SD Zafar, SY Blobe, GC Pang, H Honeycutt, W Sutton, L Hurwitz, HI	2011	50
	A phase I study of ABT-510 plus bevacizumab in advanced solid tumors Journal:Cancer Medicine	Uronis, HE Cushman, SM Bendell, JC Blobe, GC Morse, MA Nixon, AB Dellinger, A Starr, MD Li, H Meadows, K Gockerman, J Pang, HMH Hurwitz, HI	2013	82
	Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors Journal:Invest New Drugs	Rangwala, F Bendell, JC Kozloff, MF Arrowood, CC Dellinger, A Meadows, J Tourt-Uhlig, S Murphy, J Meadows, KL Starr, A Broderick, S Brady, JC Cushman, SM Morse, MA Uronis, HE Hsu, SD Zafar, SY Wallace, J Starodub, AN Strickler, JH Pang, HMH Nixon, AB Hurwitz, HI	2014	54
	Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer Journal:Investigational New Drugs	Strickler, JH McCall, S Nixon, AB Brady, JC Pang, H Rushing, C Cohn, A Starodub, A Arrowood, C Haley, S Meadows, KL Morse, MA Uronis, HE Blobe, GC Hsu, SD Zafar, SY Hurwitz, HI	2014	49
	A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors Journal:Cancer Chemotherapy and Pharmacology	Uronis, HE Jia, J Bendell, J Howard, L Ready, NA Lee, PA Starr, MD Dellinger, A Pang, HMH Nixon, AB	2015	61

Showing results 1 to 7 of 7